日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

一项针对 HER2 过表达的晚期子宫内膜癌和癌肉瘤的 2 期 zanidatamab 试验 (ZW25-IST-2)

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2023.12.028
Lumish, Melissa; Chui, M Herman; Zhou, Qin; Iasonos, Alexia; Sarasohn, Debra; Cohen, Seth; Friedman, Claire; Grisham, Rachel; Konner, Jason; Kyi, Chrisann; Rubinstein, Maria; Troso-Sandoval, Tiffany; Aghajanian, Carol; Makker, Vicky
肿瘤
子宫内膜癌
HER2
肿瘤免疫
发表日期：2024
文献求助 收藏

Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission

一项针对处于二度或三度缓解期的WT1表达卵巢癌患者的I期研究，评估多价WT1肽疫苗（Galinpepimut-S）联合纳武利尤单抗的疗效。

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15051458
Manning-Geist, Beryl L; Gnjatic, Sacha; Aghajanian, Carol; Konner, Jason; Kim, Sarah H; Sarasohn, Debra; Soldan, Krysten; Tew, William P; Sarlis, Nicholas J; Zamarin, Dmitriy; Kravetz, Sara; Laface, Ilaria; Rasalan-Ho, Teresa; Qi, Jingjing; Wong, Phillip; Sabbatini, Paul J; O'Cearbhaill, Roisin E
肿瘤
WT1
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

度伐利尤单抗联合或不联合曲美利尤单抗治疗持续性或复发性子宫内膜癌或子宫内膜癌肉瘤患者：一项随机开放标签的2期研究

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2022.11.028
Rubinstein, Maria M; Doria, Eric Rios; Konner, Jason; Lichtman, Stuart; Zhou, Qin; Iasonos, Alexia; Sarasohn, Debra; Troso-Sandoval, Tiffany; Friedman, Claire; O'Cearbhaill, Roisin; Cadoo, Karen; Kyi, Chrisann; Cohen, Seth; Soldan, Krysten; Billinson, Eric; Caird, Imogen; Jang, Dasom; Eid, Khalil; Shah, Pooja; Guillen, Joyce; Aghajanian, Carol; Zamarin, Dmitriy; Makker, Vicky
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer

晚期子宫内膜癌患者的肿瘤乐伐替尼成瘾和停药反弹反应

期刊:Gynecologic Oncology Reports
影响因子:1.3
doi:10.1016/j.gore.2023.101258
Lam, Clarissa; Sarasohn, Debra; Weigelt, Britta; Zamarin, Dmitriy
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2023
文献求助 收藏

An Extraordinary Voice Expressed Through Humor: A Tribute to Casey Quinlan

用幽默表达非凡之声：致敬凯西·奎因兰

期刊:Journal of Participatory Medicine
影响因子:
doi:10.2196/54527
Woods, Susan S; Oldenburg, Jan; van Leeuwen, Daniel; Sarasohn-Kahn, Jane; Hudson, Matthew F
发表日期：2023
文献求助 收藏

Waxing and waning pattern of mTOR inhibitor-associated pneumonitis in renal cell carcinoma patients: A retrospective observational study

肾细胞癌患者mTOR抑制剂相关性肺炎的波动模式：一项回顾性观察研究

期刊:Clinical Imaging
影响因子:1.5
doi:10.1016/j.clinimag.2020.10.052
Gluskin, Jill; Plodkowski, Andrew; Girshman, Jeffrey; Sarasohn, Debra; Viteri-Jusué, Ainhoa; Hayan, Sumar; Torrisi, Jean
肺炎
肿瘤
mTOR
肿瘤免疫
肾癌
细胞生物学
发表日期：2021
文献求助 收藏

A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative

一项旨在改善晚期卵巢癌患者初次肿瘤细胞减灭术疗效的多模式分诊算法：纪念斯隆-凯特琳癌症中心卵巢癌团队计划

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2020.05.041
Straubhar, Alli M; Filippova, Olga T; Cowan, Renee A; Lakhman, Yulia; Sarasohn, Debra M; Nikolovski, Ines; Torrisi, Jean M; Ma, Weining; Abu-Rustum, Nadeem R; Gardner, Ginger J; Sonoda, Yukio; Zivanovic, Oliver; Chi, Dennis S; Long Roche, Kara
肿瘤
肿瘤免疫
卵巢癌
细胞生物学
肿瘤细胞
发表日期：2020
文献求助 收藏

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

一项针对新诊断卵巢癌的I期剂量递增研究，评估腹腔内顺铂、静脉/腹腔内紫杉醇、贝伐珠单抗和奥拉帕尼的联合用药疗效。

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2020.01.018
Cadoo, Karen A; Grisham, Rachel N; O'Cearbhaill, Roisin E; Boucicaut, Nicole N; Henson, Melissa; Iasonos, Alexia; Zhou, Qin; Sarasohn, Debra M; Gallagher, Jacqueline; Kravetz, Sara; Zamarin, Dmitriy; Makker, Vicky; Sabbatini, Paul J; Tew, William P; Aghajanian, Carol; Konner, Jason A
肿瘤
肿瘤免疫
卵巢癌
发表日期：2020
文献求助 收藏

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia

罗米司亭治疗化疗引起的血小板减少症

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.18.01931
Soff, Gerald A; Miao, Yimei; Bendheim, Gemma; Batista, Jeanette; Mones, Jodi V; Parameswaran, Rekha; Wilkins, Cy R; Devlin, Sean M; Abou-Alfa, Ghassan K; Cercek, Andrea; Kemeny, Nancy E; Sarasohn, Debra M; Mantha, Simon
血小板
发表日期：2019
文献求助 收藏

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer

一项多中心研究评估了术前计算机断层扫描和CA-125预测晚期上皮性卵巢癌初次肿瘤细胞减灭术后肉眼可见残留病灶的能力

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2017.02.020
Suidan, Rudy S; Ramirez, Pedro T; Sarasohn, Debra M; Teitcher, Jerrold B; Iyer, Revathy B; Zhou, Qin; Iasonos, Alexia; Denesopolis, John; Zivanovic, Oliver; Long Roche, Kara C; Sonoda, Yukio; Coleman, Robert L; Abu-Rustum, Nadeem R; Hricak, Hedvig; Chi, Dennis S
肿瘤
肿瘤免疫
卵巢癌
细胞生物学
肿瘤细胞
发表日期：2017
文献求助 收藏